Home > Insider Trading > Filing (0001744981-19-000003)

Filing Details

Accession Number:: 0001744981-19-000003
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-11-26 17:50:56
Reporting Period:: 2019-11-22

Accepted Time:: 2019-11-26 17:50:56
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1595585	Tricida Inc.	TCDA	Pharmaceutical Preparations (2834)	463372526

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1629421	L.p. Ii-B Fund Capital Sibling	500 Yale Ave N Seattle WA 98109	No	No	No	Yes
1744973	Sibling Capital Ventures Ii Llc	500 Yale Ave N Seattle WA 98109	No	No	No	Yes
1744981	M. Brian Isern	500 Yale Ave N Seattle WA 98109	No	No	Yes	Yes

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2019-11-22	48,030	$40.53	2,906,184	No	4	S	Indirect	By Sibling Capital Fund II-B L.P.
Common Stock	Disposition	2019-11-22	132,834	$41.17	2,773,350	No	4	S	Indirect	By Sibling Capital Fund II-B L.P.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	By Sibling Capital Fund II-B L.P.
No	4	S	Indirect	By Sibling Capital Fund II-B L.P.

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	777,411	Indirect	By Sibling Capital Fund II-A L.P.
Common Stock	1,810,195	Indirect	By Sibling Capital Fund II-C L.P.
Common Stock	599,379	Indirect	By Sibling Capital Fund II-D L.P.
Common Stock	463,158	Indirect	By Sibling Insiders Fund II L.P.

Footnotes

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.01 to $40.89, inclusive. Each Reporting Person undertakes to provide to Tricida, Inc., any security holder of Tricida, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.90 to $41.61, inclusive.
The shares are held directly by Sibling Capital Fund II-B L.P. ("Sibling B"). Sibling Capital Ventures II LLC ("SCV II") is the sole general partner of Sibling B. As co-manager of SCV II, Brian M. Isern may be deemed to be an indirect beneficial owner of such shares.
The shares are held directly by Sibling Capital Fund II-A L.P. ("Sibling A"). Sibling Capital Ventures LLC ("SCV") is the sole general partner of Sibling A. As co-manager of SCV, Brian M. Isern may be deemed to be an indirect beneficial owner of such shares.
The shares are held directly by Sibling Capital Fund II-C L.P. ("Sibling C"). Sibling Capital Ventures III LLC ("SCV III") is the sole general partner of Sibling C. As co-manager of SCV III, Brian M. Isern may be deemed to be an indirect beneficial owner of such shares.
The shares are held directly by Sibling Capital Fund II-D L.P. ("Sibling D"). Sibling Capital Ventures IV LLC ("SCV IV") is the sole general partner of Sibling D. As co-manager of SCV IV, Brian M. Isern may be deemed to be an indirect beneficial owner of such shares.
The shares are held directly by Sibling Insiders Fund II L.P. ("Sibling Insiders Fund"). Sibling Insiders II LLC ("Sibling Insiders LLC") is the sole general partner of Sibling Insiders Fund. As co-manager of Sibling Insiders LLC, Brian M. Isern may be deemed to be an indirect beneficial owner of such shares.
For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise.